Nyumbani › Kutokwa na Damu › Washington › Seattle
Majaribio ya kliniki ya Kutokwa na Damu katika Seattle, WA
Masomo 5 ya Kutokwa na Damu yanatafuta washiriki katika vituo vya Seattle na maeneo yake (ndani ya takriban maili 30). Fungua somo kuona nani anaweza kujiunga na jinsi ya kuwasiliana na timu ya utafiti.
Maandishi rasmi ya utafiti (Kiingereza)
Unavutia washiriki kwa utafiti hapa? Weka juu ya ukurasa huu — $99 kwa siku 30 →
Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively
InaajiriHatua 3
- Washington Institute for Coagulation, Seattle
CAlcium and VAsopressin Following Injury Early Resuscitation (CAVALIER) Trial
InaajiriHatua 2
- University of Washington Harborview Medical Center, Seattle
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
InaajiriHatua 3
- University of Washingto, Seattle
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
InaajiriHatua 3
- University of Washingto, Seattle
Hemophilia A Research Program
InaajiriUtafiti wa uchunguziWajitolea wenye afya wanakaribishwa
- University of Washington, Seattle
Majaribio ya Kutokwa na Damu katika miji mingine
- Boston, MAUtafiti 10
- New York City, NYUtafiti 8
- Houston, TXUtafiti 7
- Cleveland, OHUtafiti 6
- Atlanta, GAUtafiti 6
- Chicago, ILUtafiti 6
- Indianapolis, INUtafiti 5
- Philadelphia, PAUtafiti 5
- Durham, NCUtafiti 5
- St. Louis, MOUtafiti 5
- Cedar Rapids, IAUtafiti 4
- San Diego, CAUtafiti 4
Masomo mengine katika Seattle
- Saratani ya Mapafu Isiyo na Selu NdogoUtafiti 53
- Saratani (aina zote)Utafiti 49
- Saratani ya ProstateUtafiti 42
- Leukemia ya Myeloid ya GhaflaUtafiti 40
- Saratani ya MatitiUtafiti 39
- Saratani ya MetastasiUtafiti 39
- Kansari ya kolorektaliUtafiti 34
- Saratan ya MapafuUtafiti 33
- Kansari ya MayaiUtafiti 30
- Multiple MyelomaUtafiti 22
- Sindromu za MyelodysplasticUtafiti 21
- Leukemia ya Lymphoblastic ya GhaflaUtafiti 21
Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.